| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $114.2M | +10.4% |
| Cost of Revenue | $1.0M | +110.3% |
| R&D Expense | $79.3M | -49.0% |
| SG&A Expense | $54.4M | -24.3% |
| Operating Income | -$20.2M | +83.3% |
| Pre-tax Income | -$3.1M | +98.7% |
| Income Tax | $0 | — |
| Net Income | -$3.1M | +98.7% |
| EPS (Basic) | $0.00 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.0M | -92.6% |
| Accounts Receivable | $1.8M | +349.9% |
| Current Assets | $133.4M | +192.8% |
| Total Assets | $226.8M | +0.2% |
| Current Liabilities | $323.5M | +46.1% |
| Long-term Debt | $44.7M | +34.6% |
| Stockholders' Equity | -$271.1M | +16.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$77.2M | +51.2% |
| Capital Expenditures | $6K | -99.0% |
| Investing Cash Flow | $1.2M | +4322.2% |
| Financing Cash Flow | $36.6M | -70.2% |
| Free Cash Flow | -$77.2M | +51.4% |
| +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |